Overview
- 199 inspections across 162 sites are on record.
- 538 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-01-23.
At a glance
Inspections
199
Sites
162
Observations
538
Career since
Jan 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| ImmuCell Corporation | 23 Jan 2024 | Animal Drugs & Feeds | On file |
| Aekyung Industrial Co., Ltd. | 17 Nov 2023 | Human Drugs | View 483 → |
| C&T Dream Co., Ltd. | 10 Nov 2023 | Human Drugs | View 483 → |
| Imine Co., Ltd. | 3 Nov 2023 | Human Drugs | |
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 13 Oct 2023 | Human Drugs |
Sites inspected
ImmuCell CorporationPortland, United States1 insp.
Aekyung Industrial Co., Ltd.Cheongyang-Gun, Korea (the Republic of)1 insp.
C&T Dream Co., Ltd.Cheonan, Korea (the Republic of)1 insp.
Imine Co., Ltd.Osan, Korea (the Republic of)1 insp.
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCAndover, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Erik W Koester26 shared
Jonah S Ufferfilge5 shared
John P Mistler5 shared
Sean R Marcsisin3 shared
Megan A Haggerty3 shared
Margaret E Walsh3 shared
Slater K Bartlett3 shared
Kristina L Conroy2 shared
Daniel L Zheng2 shared
Rachael O Oyewole2 shared
Full investigator report
Get the verbatim findings behind Robert J Martin's 538 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site